Regeneron Pharmaceuticals (REGN) Interest & Investment Income (2009 - 2017)
Regeneron Pharmaceuticals (REGN) recorded quarterly Interest & Investment Income of -$6.0 million in Q4 2017, up 2.38% quarter-over-quarter from -$6.2 million in Q3 2017, and down 114.92% on a YoY basis from $40.4 million in Q4 2016.
Regeneron Pharmaceuticals (REGN) Interest & Investment Income (2009 - 2017) Analysis & Trends
Regeneron Pharmaceuticals' Interest & Investment Income history runs 9 years deep, the most recent figure standing at -$6.0 million for Q4 2017.
- In Q4 2017, Interest & Investment Income fell 114.92% year-over-year to -$6.0 million; the TTM figure through Dec 2017 stood at -$25.1 million (down 249.12% YoY), while the FY2017 annual figure was -$25.1 million, down 249.12% from the prior year.
- Interest & Investment Income was -$6.0 million for Q4 2017 at Regeneron Pharmaceuticals, up from -$6.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.1 million in Q3 2015 to a low of -$18.2 million in Q4 2015.
- Historically, Interest & Investment Income has averaged -$2.5 million across 5 years, with a median of -$873500.0 in 2016.
- The sharpest annual moves came in 2014 and 2016: Interest & Investment Income surged 105.48% in 2014, then tumbled 1566.67% in 2016.
- A 5-year view of Interest & Investment Income shows it stood at -$2.3 million in 2013, then soared by 174.24% to $1.7 million in 2014, then tumbled by 1186.11% to -$18.2 million in 2015, then jumped by 84.58% to -$2.8 million in 2016, then plunged by 114.92% to -$6.0 million in 2017.
- The last three Interest & Investment Income figures came in at -$6.0 million (Q4 2017), -$6.2 million (Q3 2017), and -$5.4 million (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -6.04 Mn |
| Sep 30, 2017 | -6.18 Mn |
| Jun 30, 2017 | -5.40 Mn |
| Mar 31, 2017 | -7.50 Mn |
| Dec 31, 2016 | -2.81 Mn |
| Sep 30, 2016 | -496,000.00 |
| Jun 30, 2016 | -1.25 Mn |
| Mar 31, 2016 | -2.64 Mn |
| Dec 31, 2015 | -18.21 Mn |
| Sep 30, 2015 | 2.14 Mn |
| Jun 30, 2015 | 1.65 Mn |
| Mar 31, 2015 | 180,000.00 |
| Jun 30, 2014 | 1.68 Mn |
| Mar 31, 2014 | 937,000.00 |
| Dec 31, 2013 | -2.26 Mn |
| Sep 30, 2013 | 618,000.00 |
| Jun 30, 2013 | 954,000.00 |
| Mar 31, 2013 | 456,000.00 |
| Dec 31, 2012 | 384,000.00 |
| Sep 30, 2012 | 517,000.00 |